TransMedics Group, Inc. Forecast, price target & analysts
TransMedics Group, Inc. Target price 2026 - Analyst rating & recommendation
TransMedics Group, Inc. Classifications & Recommendation
TransMedics Group, Inc. Price Target
| Target Price | $105.06 |
| Price | $87.56 |
| Potential |
19.99%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target TransMedics Group, Inc. 2027 .
The average TransMedics Group, Inc. target price is $105.06.
This is
19.99%
register free of charge
$141.75
61.89%
register free of charge
$65.65
25.02%
register free of charge
|
|
| A rating was issued by 19 analysts: 13 Analysts recommend TransMedics Group, Inc. to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the TransMedics Group, Inc. stock has an average upside potential 2027 of
19.99%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2029
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 605.49 | 756.88 |
| 37.13% | 25.00% | |
| EBITDA Margin | 17.97% | 19.07% |
| 110.41% | 6.15% | |
| Net Margin | 31.43% | 7.32% |
| 291.33% | 76.71% |
15 Analysts have issued a sales forecast TransMedics Group, Inc. 2026 . The average TransMedics Group, Inc. sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an TransMedics Group, Inc. EBITDA forecast 2026. The average TransMedics Group, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
15 TransMedics Group, Inc. Analysts have issued a net profit forecast 2026. The average TransMedics Group, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 4.69 | 1.60 |
| 364.36% | 65.88% | |
| P/E | 54.72 | |
| EV/Sales | 4.53 |
15 Analysts have issued a TransMedics Group, Inc. forecast for earnings per share. The average TransMedics Group, Inc. EPS is
This results in the following potential growth metrics and future valuations:
TransMedics Group, Inc....
Current TransMedics Group, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| TD Cowen |
Locked
➜
Locked
|
Locked | Sep 08 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Aug 03 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Jul 28 2026 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Jul 06 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Jul 01 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
TD Cowen:
Locked
➜
Locked
|
Sep 08 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Aug 03 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Jul 28 2026 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Jul 06 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Jul 01 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
